guest ::
| Home > Publications Database > KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. > print |
| Home > Publications Database > KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. > print |
| 001 | 139386 | ||
| 005 | 20240314115347.0 | ||
| 024 | 7 | _ | |a 2211-1247 |2 ISSN |
| 024 | 7 | _ | |a 10.1016/j.celrep.2017.06.072 |2 doi |
| 024 | 7 | _ | |a pmid:28723559 |2 pmid |
| 024 | 7 | _ | |a altmetric:22139923 |2 altmetric |
| 024 | 7 | _ | |a 2639-1856 |2 ISSN |
| 037 | _ | _ | |a DZNE-2020-05708 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Kerimoglu, Cemil |0 P:(DE-HGF)0 |b 0 |
| 245 | _ | _ | |a KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions. |
| 260 | _ | _ | |a [New York, NY] |c 2017 |b Elsevier |
| 264 | _ | 1 | |3 print |2 Crossref |b Elsevier BV |c 2017-07-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1710344290_30567 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Kmt2a and Kmt2b are H3K4 methyltransferases of the Set1/Trithorax class. We have recently shown the importance of Kmt2b for learning and memory. Here, we report that Kmt2a is also important in memory formation. We compare the decrease in H3K4 methylation and de-regulation of gene expression in hippocampal neurons of mice with knockdown of either Kmt2a or Kmt2b. Kmt2a and Kmt2b control largely distinct genomic regions and different molecular pathways linked to neuronal plasticity. Finally, we show that the decrease in H3K4 methylation resulting from Kmt2a knockdown partially recapitulates the pattern previously reported in CK-p25 mice, a model for neurodegeneration and memory impairment. Our findings point to the distinct functions of even closely related histone-modifying enzymes and provide essential insight for the development of more efficient and specific epigenetic therapies against brain diseases. |
| 536 | _ | _ | |a 342 - Disease Mechanisms and Model Systems (POF3-342) |0 G:(DE-HGF)POF3-342 |c POF3-342 |f POF III |x 0 |
| 542 | _ | _ | |i 2017-07-01 |2 Crossref |u https://www.elsevier.com/tdm/userlicense/1.0/ |
| 542 | _ | _ | |i 2017-06-26 |2 Crossref |u http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Myeloid-Lymphoid Leukemia Protein |0 149025-06-9 |2 NLM Chemicals |
| 650 | _ | 7 | |a Histone-Lysine N-Methyltransferase |0 EC 2.1.1.43 |2 NLM Chemicals |
| 650 | _ | 7 | |a Kmt2a protein, mouse |0 EC 2.1.1.43 |2 NLM Chemicals |
| 650 | _ | 2 | |a Animals |2 MeSH |
| 650 | _ | 2 | |a Gene Expression Regulation, Enzymologic |2 MeSH |
| 650 | _ | 2 | |a Hippocampus: enzymology |2 MeSH |
| 650 | _ | 2 | |a Histone-Lysine N-Methyltransferase: biosynthesis |2 MeSH |
| 650 | _ | 2 | |a Histone-Lysine N-Methyltransferase: genetics |2 MeSH |
| 650 | _ | 2 | |a Memory |2 MeSH |
| 650 | _ | 2 | |a Methylation |2 MeSH |
| 650 | _ | 2 | |a Mice |2 MeSH |
| 650 | _ | 2 | |a Myeloid-Lymphoid Leukemia Protein: biosynthesis |2 MeSH |
| 650 | _ | 2 | |a Myeloid-Lymphoid Leukemia Protein: genetics |2 MeSH |
| 650 | _ | 2 | |a Neurons: enzymology |2 MeSH |
| 700 | 1 | _ | |a Sakib, M Sadman |0 P:(DE-2719)2812054 |b 1 |u dzne |
| 700 | 1 | _ | |a Jain, Gaurav |0 P:(DE-2719)2811223 |b 2 |u dzne |
| 700 | 1 | _ | |a Benito, Eva |0 P:(DE-2719)2810482 |b 3 |u dzne |
| 700 | 1 | _ | |a Burkhardt, Susanne |0 P:(DE-2719)2810773 |b 4 |u dzne |
| 700 | 1 | _ | |a Capece, Vincenzo |0 P:(DE-2719)2810626 |b 5 |u dzne |
| 700 | 1 | _ | |a Kaurani, Lalit |0 P:(DE-2719)2812832 |b 6 |u dzne |
| 700 | 1 | _ | |a Halder, Rashi |0 P:(DE-2719)2810512 |b 7 |u dzne |
| 700 | 1 | _ | |a Agís-Balboa, Roberto Carlos |0 P:(DE-2719)9000006 |b 8 |u dzne |
| 700 | 1 | _ | |a Stilling, Roman |0 P:(DE-2719)9000302 |b 9 |u dzne |
| 700 | 1 | _ | |a Urbanke, Hendrik |0 P:(DE-2719)2811034 |b 10 |u dzne |
| 700 | 1 | _ | |a Kranz, Andrea |0 P:(DE-HGF)0 |b 11 |
| 700 | 1 | _ | |a Stewart, A Francis |0 P:(DE-HGF)0 |b 12 |
| 700 | 1 | _ | |a Fischer, Andre |0 P:(DE-2719)2000047 |b 13 |e Last author |u dzne |
| 773 | 1 | 8 | |a 10.1016/j.celrep.2017.06.072 |b : Elsevier BV, 2017-07-01 |n 3 |p 538-548 |3 journal-article |2 Crossref |t Cell Reports |v 20 |y 2017 |x 2211-1247 |
| 773 | _ | _ | |a 10.1016/j.celrep.2017.06.072 |g Vol. 20, no. 3, p. 538 - 548 |0 PERI:(DE-600)2649101-1 |n 3 |q 20:3<538 - 548 |p 538-548 |t Cell reports |v 20 |y 2017 |x 2211-1247 |
| 856 | 4 | _ | |y OpenAccess |u https://pub.dzne.de/record/139386/files/DZNE-2020-05708.pdf |
| 856 | 4 | _ | |y OpenAccess |x pdfa |u https://pub.dzne.de/record/139386/files/DZNE-2020-05708.pdf?subformat=pdfa |
| 909 | C | O | |o oai:pub.dzne.de:139386 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 1 |6 P:(DE-2719)2812054 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 2 |6 P:(DE-2719)2811223 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2810482 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 4 |6 P:(DE-2719)2810773 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2810626 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 6 |6 P:(DE-2719)2812832 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 7 |6 P:(DE-2719)2810512 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 8 |6 P:(DE-2719)9000006 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 9 |6 P:(DE-2719)9000302 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 10 |6 P:(DE-2719)2811034 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 13 |6 P:(DE-2719)2000047 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-342 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Disease Mechanisms and Model Systems |x 0 |
| 914 | 1 | _ | |y 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-17 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND 4.0 |0 LIC:(DE-HGF)CCBYNCND4 |2 HGFVOC |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CELL REP : 2021 |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0501 |2 StatID |b DOAJ Seal |d 2021-01-26T13:08:57Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0500 |2 StatID |b DOAJ |d 2021-01-26T13:08:57Z |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-17 |
| 915 | _ | _ | |a OpenAccess |0 StatID:(DE-HGF)0510 |2 StatID |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b DOAJ : Blind peer review |d 2021-01-26T13:08:57Z |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CELL REP : 2021 |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-17 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-17 |
| 920 | 1 | _ | |0 I:(DE-2719)1410002 |k AG Fischer |l Epigenetics and Systems Medicine in Neurodegenerative Diseases |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1440012 |k AG Bonn 2 |l Computational Systems Biology |x 1 |
| 920 | 1 | _ | |0 I:(DE-2719)1410004 |k AG Sananbenesi |l Genome Dynamics in Neurodegenerative Diseases |x 2 |
| 920 | 1 | _ | |0 I:(DE-2719)6000014 |k Göttingen common |l Göttingen common |x 3 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-2719)1410002 |
| 980 | _ | _ | |a I:(DE-2719)1440012 |
| 980 | _ | _ | |a I:(DE-2719)1410004 |
| 980 | _ | _ | |a I:(DE-2719)6000014 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|